Sterling
Moderna logo
Moderna
BioNTech logo
BioNTech

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Moderna 0.145, BioNTech 0.114.

Moderna vs BioNTech Net Worth and Market Cap

Moderna (MRNA) and BioNTech (BNTX) are peers in Vaccines. Moderna reported revenue of $145M as of Q2 2026, compared with $114M for BioNTech. Moderna leads on revenue.

Moderna's gross margin is 35.9% versus 8.1% for BioNTech. Moderna's net margin is -539.3% versus -777.3% for BioNTech.

Key differences

  • Revenue growth from Q2 2025 to Q2 2026: Moderna +2.1%, BioNTech -59.6%.
  • Both made operating losses in their latest quarter: Moderna at a -562.1% margin, BioNTech at -897.8%.
  • Moderna's KPIs on Sterling include Cash, Cash Equivalents and Investments (Quarterly) and Net Product Sales vs Deferred Revenue (Quarterly).
  • BioNTech's KPIs on Sterling include Cash, Cash Equivalents, and Security Investments (Quarterly) and COMIRNATY Doses as Printed.

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Moderna, BioNTech.
MetricModernaBioNTech
Market Cap--
Revenue$145.00M$114.00M
Cost of Revenue$93.00M$105.00M
Gross Profit$52.00M$9.00M
Operating Income$-815.00M$-1.02B
Net Income$-782.00M$-886.00M
R&D Expense$651.00M$595.00M
Earnings Per Share-$1.96-$3.5
Gross Margin35.9%8.1%
Operating Margin-562.1%-897.8%
Net Profit Margin-539.3%-777.3%
Free Cash Flow$-563.00M$-48.00M
Cumulative Free Cash Flow$7.37B$19.56B
Operating Cash Flow$-526.00M$12.00M
Cash & Equivalents$1.72B$10.52B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites